Cargando…

Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019

Purpose: The study aimed to quantify the global trends of the incidence rates of multidrug-resistant (MDR) tuberculosis (MDR-TB) and extensively drug-resistant (XDR) tuberculosis (XDR-TB). Methods: Cases, age-standardized rates (ASRs), and incidence rates of MDR-TB and XDR-TB during 2010–2019 were o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bu, Qingting, Qiang, Rong, Fang, Lingyan, Peng, Xiaokang, Zhang, Hua, Cheng, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998482/ https://www.ncbi.nlm.nih.gov/pubmed/36909179 http://dx.doi.org/10.3389/fphar.2023.1156249

Ejemplares similares

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China
por: Yang, Xiujun, et al.
Publicado: (2015)

Analysis of the Global Disease Burden of Down Syndrome Using YLDs, YLLs, and DALYs Based on the Global Burden of Disease 2019 Data
por: Bu, Qingting, et al.
Publicado: (2022)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2013)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database
por: Pan, Zhenyu, et al.
Publicado: (2020)

Trends of the incidence of drug use disorders from 1990 to 2017: an analysis based on the Global Burden of Disease 2017 data
por: Pan, Zhenyu, et al.
Publicado: (2020)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2015)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Epidemiological features and temporal trends of HIV-negative tuberculosis burden from 1990 to 2019: a retrospective analysis based on the Global Burden of Disease Study 2019
por: Chen, Yuqian, et al.
Publicado: (2023)

Global Trends in Incidence and Burden of Urolithiasis from 1990 to 2019: An Analysis of Global Burden of Disease Study Data
por: Lang, Jacob, et al.
Publicado: (2022)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study
por: Zhang, Tongchao, et al.
Publicado: (2021)

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
por: Hameed, H. M. Adnan, et al.
Publicado: (2018)

Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
por: Li, Min, et al.
Publicado: (2022)

MDR and XDR typhoid fever-a threat for the current decade?
por: Pustake, Manas, et al.
Publicado: (2021)

High burden of MDR, XDR, PDR, and MBL producing Gram negative bacteria causing infections in Kermanshah health centers during 2019–2020
por: Kadivarian, Sepide, et al.
Publicado: (2023)

Characteristics and Treatment Outcomes of Patients with MDR and XDR Tuberculosis in a TB Referral Hospital in Beijing: A 13-Year Experience
por: Liu, Cui Hua, et al.
Publicado: (2011)

Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019
por: Tian, Yi-Qun, et al.
Publicado: (2023)

Classification of Mycobacterium tuberculosis DR, MDR,XDR Isolates and Identification of Signature MutationPattern of Drug Resistance
por: Prasanna, Akshatha, et al.
Publicado: (2019)

Global trends in the burden of esophageal cancer, 1990−2019: results from the Global Burden of Disease Study 2019
por: Jiang, Yu, et al.
Publicado: (2023)

Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
por: Lin, Longfei, et al.
Publicado: (2021)

The Global Trends and Regional Differences in Incidence of Dengue Infection from 1990 to 2019: An Analysis from the Global Burden of Disease Study 2019
por: Du, Min, et al.
Publicado: (2021)

Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2023)

Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019
por: Chen, Weihua, et al.
Publicado: (2023)

The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
por: Zhang, Shiwen, et al.
Publicado: (2022)

Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019
por: Qian, Zhen, et al.
Publicado: (2023)

Global trends in the incidence and mortality of asthma from 1990 to 2019: An age-period-cohort analysis using the global burden of disease study 2019
por: Cao, Yu, et al.
Publicado: (2022)

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
por: Nguyen, Thi Mai Phuong, et al.
Publicado: (2022)

Trends in the Incidence and DALYs of Urolithiasis From 1990 to 2019: Results From the Global Burden of Disease Study 2019
por: Li, Shasha, et al.
Publicado: (2022)

Global burden and trends of lung cancer incidence and mortality
por: Li, Chao, et al.
Publicado: (2023)

Global, regional, and national trends of syphilis from 1990 to 2019: the 2019 global burden of disease study
por: Tao, Yu-Ting, et al.
Publicado: (2023)

Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India
por: Balaji, V., et al.
Publicado: (2010)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017)

Global, regional, and national burden of digestive diseases: findings from the global burden of disease study 2019
por: Wang, Fang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4nbhq5h38aufpmach1tqdcfkj